ACADIA Pharmaceuticals Inc Q2 2024 Earnings Call Transcript Highlights Strong Revenue ...

ACAD Stock  USD 16.32  0.03  0.18%   
About 54% of ACADIA Pharmaceuticals' shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding ACADIA Pharmaceuticals suggests that some traders are interested. The current market sentiment, together with ACADIA Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use ACADIA Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Total Revenue 242 million, up 46 percent year-over-year.DAYBUE Net Product Sales 84.6 million, up 11 percent sequentially.NUPLAZID Net Product Sales 157.4 million, up

Read at gurufocus.com
Gurufocus Stories at Macroaxis
  

ACADIA Pharmaceuticals Current Investor Sentiment

Panic Vs Confidence

54

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use ACADIA Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward ACADIA Pharmaceuticals.

ACADIA Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards ACADIA Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

ACADIA Pharmaceuticals Fundamental Analysis

We analyze ACADIA Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ACADIA Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ACADIA Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Liabilities

Current Liabilities Comparative Analysis

ACADIA Pharmaceuticals is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

ACADIA Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ACADIA Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of ACADIA Pharmaceuticals could also be used in its relative valuation, which is a method of valuing ACADIA Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

ACADIA Pharmaceuticals Related Equities

CABACabaletta Bio   26.91   
0%
100.0%
FBIOFortress Biotech   16.39   
0%
60.0%
RVPHReviva Pharmaceuticals   8.77   
0%
32.0%
HEPAHepion Pharmaceuticals   4.69   
0%
17.0%
ATHAAthira Pharma   1.54   
0%
5.0%
BPMCBlueprint Medicines   1.35   
0%
5.0%
KRYSKrystal Biotech   0.26   
0%
1.0%
AKROAkero Therapeutics   0.22   
1.0%
0%
MDGLMadrigal Pharmaceuticals   0.98   
3.0%
0%
TERNTerns Pharmaceuticals   1.58   
5.0%
0%
PTCTPTC Therapeutics   2.73   
10.0%
0%
VKTXViking Therapeutics   2.88   
10.0%
0%
SRPTSarepta Therapeutics   3.33   
12.0%
0%

Complementary Tools for ACADIA Stock analysis

When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance